Spironolactone on Rat Corneal Neovascularization

ZHOU Li-Juan,LU Xiao-He,YUAN Wei,GONG Yu-Bo
2009-01-01
Abstract:Objective To explore the effects and mechanisms of spironolactone,a aldosterone receptor antagon,on corneal neovascularization(CNV).Methods CNV was induced by sutures on 20 female Sprague-Dawley rats.The experimental rats then were divided randomly into CNV control group and spironolactone group(treated orally with 150 mg·kg-1·d-1),and compared with normal control group,10 in each group.CNV was observed at the 3rd,7th and 12th day,and CNV area was calculated in different groups.The cornea with neovascularization was observed by histopathological method and the expression of vascular endothelial growth factor(VEGF) was detected by immunohistochemistry at the 12th day.Results At different observing times,the CNV area in control group were(2.549±1.315)mm2,(13.998±2.999)mm2,(23.266±2.833)mm2,respectively.In the spironolactone group was 0 mm2,(8.454±2.830)mm2,(15.189±3.676) mm2,the difference was significant between two groups(P0.05).Expression of VEGF in cornea was 22.660±4.158 in control group,and 12.460±1.754 in the spironolactone group.Compared with control group less expression of VEGF was detected in the spironolactone group,the difference was significant (P0.05).Conclusion Spironolactone by oral is effective to inhibit rat CNV induced by sutures,which may be associated with the depression of VEGF.
What problem does this paper attempt to address?